Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports
This report describes the cases of two patients with mycosis fungoides and Sézary syndrome (MF/SS) who achieved clinical benefit with mogamulizumab combination therapies. Case 1 is a 56-year-old male with stage IIIB (T4NxM0B1) MF, which later progressed into SS, with ongoing skin symptoms (erythema,...
Saved in:
| Main Authors: | Andrea Bernardelli, Carlo Visco |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Therapeutic Advances in Hematology |
| Online Access: | https://doi.org/10.1177/20406207251317165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycosis fungoides and Sézary syndrome
by: Ieva Saulite, et al.
Published: (2021-06-01) -
Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome
by: LG Gorenkova, et al.
Published: (2017-07-01) -
Current Opportunities for Treatment Optimization of Mycosis Fungoides and Sezary Syndrome
by: NG Chernova, et al.
Published: (2018-01-01) -
Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab
by: Lukas D. Uleer, et al.
Published: (2025-06-01) -
Expression of Thymidine Phosphorylase in Lymph Nodes Involved with Mycosis Fungoides and Sézary Syndrome
by: Xingcao Nie, et al.
Published: (2011-01-01)